VetMedTeam - Providing Educational Pathways to Great Careers!

Continuing Education Credits
Course meets the requirements for 1 RACE hours of continuing education credit for veterinary technicians and veterinarians in jurisdictions which recognize AAVSB's RACE approval. However, participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery. RACE Subject Category: Medical; Delivery Method: Non-interactive Distance; Program Number 986090.

Continuing Education Credits

Course meets the requirements for 1 RACE hours of continuing education credit for veterinary technicians and veterinarians in jurisdictions which recognize AAVSB's RACE approval. However, participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery.

RACE Subject Category: Medical; Delivery Method: Non-interactive Distance; Program Number 986090.

Content Presenter
Dr Sue Ettinger, DVM, Diplomate ACVIM (Oncology)

Course Focus and Learning Objectives
Treatment Advances for Canine Mast Cell Tumors is a free veterinary CE offering made possible through the generous educational support of QBiotics®. This course utilizes the archive of a live presentation. The diagnosis and treatment of canine mast cell tumors requires an awareness of the latest advancements. Dr. Sue Ettinger outlines the use of cytological grading and lymph node aspiration in the diagnosis process. To aid clinicians in providing effective treatment, the doctor will share her in-the-trenches experience with STELFONTA® (tigilanol tiglate injection). She will outline her tips regarding what makes a dog a suitable candidate and, just as importantly, what does not. Dr. Ettinger includes cases from her patients including tumor destruction and wound healing. Via this presentation, clinicians can gain confidence including STELFONTA® in their treatment toolbox. Learning Objectives: Upon completion of this course, the participant should be able to discuss latest advances in canine mast cell tumor diagnosis. In addition, the participant should be able to discuss the appropriate use of STELFONTA® (tigilanol tiglate injection), including tumor, patient, and client considerations. This also includes factors critical to treatment success.

Course Focus and Learning Objectives

Treatment Advances for Canine Mast Cell Tumors is a free veterinary CE offering made possible through the generous educational support of QBiotics®.

This course utilizes the archive of a live presentation.

The diagnosis and treatment of canine mast cell tumors requires an awareness of the latest advancements. Dr. Sue Ettinger outlines the use of cytological grading and lymph node aspiration in the diagnosis process. To aid clinicians in providing effective treatment, the doctor will share her in-the-trenches experience with STELFONTA® (tigilanol tiglate injection). She will outline her tips regarding what makes a dog a suitable candidate and, just as importantly, what does not. Dr. Ettinger includes cases from her patients including tumor destruction and wound healing. Via this presentation, clinicians can gain confidence including STELFONTA® in their treatment toolbox.

Learning Objectives:

Upon completion of this course, the participant should be able to discuss latest advances in canine mast cell tumor diagnosis. In addition, the participant should be able to discuss the appropriate use of STELFONTA® (tigilanol tiglate injection), including tumor, patient, and client considerations. This also includes factors critical to treatment success.

Open Enrollment with Immediate Access and Individual Scheduling
This is an open enrollment course. Participants may enroll at any time. Upon submission of enrollment the participant is immediately added to the course. The course welcome email provides login and other important information. This is an asynchronous course, meaning it does not contain real time components. Participants do not need to be logged into the course at specific times to attend lectures or view presentations. Participants do not need to complete the course in one sitting. However, students who do not access the course within 30 days of last access will be processed as incomplete. Any activity within the course will reset to the full 30 days time allotment. Participants who are unable to complete a course may re-enroll at their convenience providing the course is still available.

Open Enrollment with Immediate Access and Individual Scheduling

This is an open enrollment course. Participants may enroll at any time. Upon submission of enrollment the participant is immediately added to the course. The course welcome email provides login and other important information.

This is an asynchronous course, meaning it does not contain real time components. Participants do not need to be logged into the course at specific times to attend lectures or view presentations.

Participants do not need to complete the course in one sitting. However, students who do not access the course within 30 days of last access will be processed as incomplete. Any activity within the course will reset to the full 30 days time allotment.

Participants who are unable to complete a course may re-enroll at their convenience providing the course is still available.

Completion Requirements
The completion requirements for this course are: complete the quiz with a score of 80% or better - multiple attempts are permitted submit the course survey Upon submission of the final completion requirement, the participant will automatically be marked as completed and the course completion email will be sent out. The participant will have immediate access to the certificate.

Free Course
Price: FREE

Follow Us & Share